Literature DB >> 11876129

Autoimmune liver disease.

Giorgina Mieli-Vergani1, Diego Vergani.   

Abstract

Autoimmune liver disorders are inflammatory liver diseases characterised histologically by a dense mononuclear cell infiltrate in the portal tract and serologically by the presence of non-organ and liver specific autoantibodies and increased levels of immunoglobulin G (IgG), in the absence of a known etiology. They usually respond to immunosuppressive treatment, which should be instituted as soon as diagnosis is made. The onset is variable and often mimics acute hepatitis. The previously accepted requirement of six month duration of symptoms before a diagnosis of autoimmune disease could be made has been abandoned.

Entities:  

Mesh:

Year:  2002        PMID: 11876129     DOI: 10.1007/bf02723785

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  25 in total

Review 1.  Mycophenolate mofetil--a new treatment for autoimmune hepatitis?

Authors:  A Dhawan; G Mieli-Vergani
Journal:  J Hepatol       Date:  2000-09       Impact factor: 25.083

2.  The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506.

Authors:  M H Cooper; G G Hartman; T E Starzl; J J Fung
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

3.  Autoimmune hepatitis as a late complication of liver transplantation.

Authors:  H M Hernandez; P Kovarik; P F Whitington; E M Alonso
Journal:  J Pediatr Gastroenterol Nutr       Date:  2001-02       Impact factor: 2.839

4.  Autoimmune hepatitis in childhood: a 20-year experience.

Authors:  G V Gregorio; B Portmann; F Reid; P T Donaldson; D G Doherty; M McCartney; A P Mowat; D Vergani; G Mieli-Vergani
Journal:  Hepatology       Date:  1997-03       Impact factor: 17.425

5.  Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine.

Authors:  S Andries; L Casamayou; C Sempoux; M Burlet; R Reding; J Bernard Otte; J P Buts; E Sokal
Journal:  Transplantation       Date:  2001-07-27       Impact factor: 4.939

6.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Authors:  F Alvarez; P A Berg; F B Bianchi; L Bianchi; A K Burroughs; E L Cancado; R W Chapman; W G Cooksley; A J Czaja; V J Desmet; P T Donaldson; A L Eddleston; L Fainboim; J Heathcote; J C Homberg; J H Hoofnagle; S Kakumu; E L Krawitt; I R Mackay; R N MacSween; W C Maddrey; M P Manns; I G McFarlane; K H Meyer zum Büschenfelde; M Zeniya
Journal:  J Hepatol       Date:  1999-11       Impact factor: 25.083

7.  Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors.

Authors:  P T Donaldson; D G Doherty; K M Hayllar; I G McFarlane; P J Johnson; R Williams
Journal:  Hepatology       Date:  1991-04       Impact factor: 17.425

Review 8.  Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases.

Authors:  A N McNair; M Moloney; B C Portmann; R Williams; I G McFarlane
Journal:  Am J Gastroenterol       Date:  1998-05       Impact factor: 10.864

9.  Primary sclerosing cholangitis in childhood.

Authors:  M el-Shabrawi; M L Wilkinson; B Portmann; G Mieli-Vergani; S K Chong; R Williams; A P Mowat
Journal:  Gastroenterology       Date:  1987-05       Impact factor: 22.682

10.  Azathioprine for long-term maintenance of remission in autoimmune hepatitis.

Authors:  P J Johnson; I G McFarlane; R Williams
Journal:  N Engl J Med       Date:  1995-10-12       Impact factor: 91.245

View more
  1 in total

Review 1.  Autoimmune hepatitis in children.

Authors:  Robert H Squires
Journal:  Curr Gastroenterol Rep       Date:  2004-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.